Mice Model Market is Expected to Reach $2.2 billion | MarketsandMarkets™

Chicago, March 18, 2024 (GLOBE NEWSWIRE) -- Mice Model market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Factors like growing investments and fundings in the field of drug discovery & development and increasing healthcare expenditure by developing countries are driving the growth of mice model market. Advancements in mice model, driven by breakthroughs in genetic engineering, are revolutionizing drug development and personalizing patient treatment. This is reshaping the pharmaceutical industry, fostering a more targeted and efficient approach to drug discovery and delivery.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308

Mice Model Market Scope:

Report Coverage	Details
Market Revenue in 2024	$1.5 billion
Estimated Value by 2029	$2.2 billion
Growth Rate	Poised to grow at a CAGR of 8.1%
Market Size Available for	2022–2029
Forecast Period	2024–2029
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Model Type & Service, Technology, Therapeutic Area, Application, and End User
Geographies Covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunity	Rising demand for disease specific mice models
Key Market Driver	Rising demand for personalized medicines in oncology

Based on model type & service, the mice model market is segmented into model type & service. The model type segment is further sub-segmented as inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. The services are further sub-segmented as breeding, cryopreservation, rederivation, quarantine, and other services. Model type segment accounted for the largest share of the global mice model market in 2023. The large share of this segment can primarily be attributed to the ability of mice models to accurately mimic human diseases and conditions, enabling researchers to study disease mechanisms and test potential treatments in a controlled environment.

Based on technology, the mice model market is segmented into CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. In 2023, CRISPR/CAS9 accounted for the largest share of the mice model market. The large share of this segment can be attributed to a more efficient and streamlined approach to gene editing compared to traditional methods. It allows for rapid generation of genetically modified mice, reducing the time and resources required for breeding and phenotyping studies. Additionally, increased availability of funds, investments, and grants, are anticipated to propel the market for CRISPR/CAS9 technology in the forecast period.

Based on therapeutic area, the mice model market is segmented into oncology, neurology, metabolic diseases, immunology, cardiovascular diseases, and other diseases. In 2023, oncology accounted for largest share of the mice model market due to the increasing prevalence of cancer which is increasing the fundings for cancer research. Moreover, growing cancer research activities are expected to drive the demand of the segment during the forecast period.

Based on application, the mice model market has been segmented into drug discovery & development, research application, and personalized medicine. In 2023, drug discovery & development accounted for the largest market share owing to increasing demand for advanced drug products for the treatment of chronic and rare diseases.

Based on end user, the mice model market has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, and CROs and CDMOs. In 2023, pharmaceutical & biotechnology companies accounted for the largest share of the mice model market. The growing research activities, supported by rising fundings for research & development of novel drug therapies drives the growth of mice model market among pharmaceutical & biotechnology companies.

The key regional markets for the global mice model market are North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America accounted for the largest share of the market. The large share of this region can be attributed to the increasing research funding and government initiatives for promoting precision medicine, abundant infrastructure, and the presence of leading key players in the region. However, during the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the increasing research activities in the field of genetic engineering and increasing research fundings, investments and collaborations by pharmaceutical and biotechnology companies for the pre-clinical research studies are projected to drive the growth of mice model market in Asia Pacific.

Buy a Mice Model Industry Report (399 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=1308

Mice Model market major players covered in the report, such as:

• Charles River Laboratories (US)
• Inotiv (US)
• THE JACKSON LABORATORY (US)
• GemPharmatech (China)
• Cyagen (US)
• Shanghai Model Organisms Center, Inc. (China)
• JSR Corporation (Japan)
• Biocytogen (China)
• TRANS GENIC INC. (Japan)
• Ozgene Pty Ltd. (Australia)
• Taconic Biosciences, Inc. (US)
• TransCure bioServices (France)
• Harbour BioMed (China)
• Marshall BioResources (US)
• genOway (France)
• Vivo Bio Tech Ltd. (India)
• ingenious targeting laboratory (US)
• Janvier Labs (France)
• Applied StemCell (US)
• Creative Animodel (US)
• JOINN Laboratories Co., Ltd. (China)
• Creative Biolabs (US)
• Crescendo Biologics (UK)
• Aragen Life Sciences (India)
• PolyGene (Switzerland)
• and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1308

This report categorizes the mice model market into the following segments:

Mice Model Market, by Model Type & Service

• Model Type
  • Inbred Mice
  • Genetically Engineered Mice
  • Hybrid/Congenic Mice
  • Outbred Mice
• Service
  • Breeding
  • Cryopreservation
  • Rederivation
  • Quarantine
  • Other services

Mice Model Market, by Technology

• CRISPR/CAS9
• Microinjection
• Embryonic Stem cell Injection
• Nuclear Transfer
• Other Technologies

Mice Model Market, by Therapeutic Area

• Oncology
• Metabolic Diseases
• Immunology
• Neurology
• Cardiovascular Diseases
• Other Therapeutic Diseases

Mice Model Market, by Application

• Drug Discovery & Development
• Research Application
• Personalized Medicine

Mice Model Market, by End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CROs & CDMOs

Mice Model Market, by region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa
  • Middle East
    • GCC Countries
      • Saudi Arabia
      • United Ara Emirates
      • Rest of GCC Countries
  • Rest of Middle East (RoME)
• Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1308

Key Market Stakeholders:

• Manufacturers and distributors of mice model products
• Mice model service providers
• Pharmaceutical and biotechnology companies
• Market research and consulting firms
• R&D centers
• Researchers and scientists
• Regulatory authorities & institutions
• Academic & research institutes
• CROs & CDMOs

Report Objectives:

• To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, end user, and region
• To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
• To profile the key players in the global mice model market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the mice model market
• To benchmark players in the mice model market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share

Related Reports:

Contract Research Organization Services Market

Humanized Mouse and Rat Model Market

Patient-Derived Xenograft/PDX Model Market

In Vitro Toxicology Testing Market

Life Science Instrumentation Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/mice-model-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/mice-model.asp

            About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com